Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
EULAR-standpunt over gebruik van (hydroxy)chloroquine voor COVID-19
apr 2020 | RA, Virale infecties